Karyopharm Therapeutics | KPTI - Operating Profit

Karyopharm Therapeutics reported $-33869000 in Operating Profit for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Operating Profit Change
Abbott ABT:US USD 1.33B 442M
Abbvie ABBV:US USD 5.5B 899M
Amgen AMGN:US USD 2.23B 508M
AstraZeneca AZN:LN USD 1.09B 151M
Astrazeneca AZN:US USD 1.09B 151M
Avrobio Inc AVRO:US USD -22985000 4.79M
Biocryst Pharmaceuticals BCRX:US USD -46311000 28.87M
Bristol Myers Squibb BMY:US USD 1.94B 528M
Eli Lilly And LLY:US USD 1.84B 159.9M
Enanta Pharmaceuticals ENTA:US USD -30013000 2.96M
GlaxoSmithKline GSK:LN GBP 1.87B 677M
Johnson & Johnson JNJ:US USD 4.2B 1.62B
Karyopharm Therapeutics KPTI:US USD -33869000 3.03M
Macrogenics MGNX:US USD 11.98M 36.94M
Merk MRK:US USD 3.51B 505M
Mirati Therapeutics MRTX:US USD -211723000 25.28M
Nektar Therapeutics NKTR:US USD -52469000 1.83M
Novartis NOVN:VX USD 1.95B 219M
Novartis NVS:US USD 1.95B 219M
Pfizer PFE:US USD 5.17B 4.24B
Regeneron Pharmaceuticals REGN:US USD 1.15B 76.9M
Roche Holding ROG:VX 5.93B 5.62B
Sangamo Biosciences SGMO:US USD -55392000 498K
Takeda 4502:JP JPY 146.99B 42.55B
Tg Therapeutics TGTX:US USD -52062000 17.1M
Ultragenyx Pharmaceutical RARE:US USD -145628000 79.44M
Xencor XNCR:US USD -42693000 4.34M
YTE INCY:US USD 70.09M 68.28M